Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review. [electronic resource]
- BMC cancer Jul 2019
- 748 p. digital
Publication Type: Case Reports; Journal Article
1471-2407
10.1186/s12885-019-5934-4 doi
Aged Antineoplastic Agents, Immunological--pharmacology Antineoplastic Agents, Phytogenic--adverse effects Antineoplastic Combined Chemotherapy Protocols--adverse effects Carboplatin--adverse effects Cystadenocarcinoma, Serous--diagnostic imaging Follow-Up Studies Humans Immunologic Factors--therapeutic use Immunotherapy--methods Magnetic Resonance Imaging Male Neoadjuvant Therapy Neoplasm Recurrence, Local Nivolumab--pharmacology Paclitaxel--adverse effects Programmed Cell Death 1 Receptor--antagonists & inhibitors Retroperitoneal Neoplasms--diagnostic imaging Treatment Outcome